Discontinuation report AGRYLIN
| Report ID | 210182 |
| Drug Identification Number | 02236859 |
| Brand name | AGRYLIN |
| Common or Proper name | Anagrelide hydrochloride capsules |
| Company Name | TAKEDA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ANAGRELIDE |
| Strength(s) | 0.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | Bottles of 100 capsules |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-02-28 |
| Actual discontinuation date | 2024-02-29 |
| Remaining supply date | 2024-06-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Remaining supply expires JUNE 2024 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-03-01 | French | Compare |
| v4 | 2024-03-01 | English | Compare |
| v3 | 2023-11-15 | French | Compare |
| v2 | 2023-11-15 | English | Compare |
| v1 | 2023-11-15 | English | Compare |
Showing 1 to 5 of 5